Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Kaleida Health |
---|---|
Information provided by: | Kaleida Health |
ClinicalTrials.gov Identifier: | NCT00467987 |
The purpose of this study is to examine the effects of testosterone deficiency in men with diabetes on atherogenesis, inflammation, cardiovascular Risk factors And adiposity .
Condition | Intervention |
---|---|
Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism. |
Drug: Androgel |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Effect of Androgel on Atherogenesis, Inflammation, Cardiovascular Risk Factors And Adiposity in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism.: a Prospective, Randomized and Controlled-Study |
Study Start Date: | June 2007 |
Estimated Study Completion Date: | June 2012 |
The purpose of this study is to examine the effects of testosterone deficiency in men with diabetes on atherogenesis, inflammation, cardiovascular Risk factors And adiposity . This will be done by comparing the changes in several body response indicators following treatment with testosterone in diabetic men with low testosterone levels and comparing them to diabetic men with low testosterone who are not treated with testosterone. These groups will also be compared with diabetic men who have normal testosterone levels
Ages Eligible for Study: | 31 Years to 60 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Barbara Hall | 716-887-5104 | bhall@kaleidahealth.org |
United States, New York | |
Millard Fillmore Hospital | |
Buffalo, New York, United States, 14209 |
Principal Investigator: | Paresh Dandona | Kaleida Health |
Study ID Numbers: | Androgel 1920 |
Study First Received: | April 27, 2007 |
Last Updated: | November 5, 2008 |
ClinicalTrials.gov Identifier: | NCT00467987 |
Health Authority: | United States: Institutional Review Board |
Atherosclerosis Arterial Occlusive Diseases Obesity Gonadal Disorders Vascular Diseases Endocrine System Diseases Arteriosclerosis |
Methyltestosterone Inflammation Testosterone 17 beta-cypionate Testosterone Hypogonadism Endocrinopathy |
Anabolic Agents Pathologic Processes Antineoplastic Agents, Hormonal Antineoplastic Agents Therapeutic Uses Physiological Effects of Drugs |
Hormones, Hormone Substitutes, and Hormone Antagonists Cardiovascular Diseases Hormones Pharmacologic Actions Androgens |